The New York Society of Security Analysts Life Sciences meeting provides an overview/outlook of the life sciences sector by Yigal Nochomovitz, Vice President of Biotech Equity Research at Morgan Stanley, followed by presentations from executives of ten emerging/mid-cap publicly traded companies developing new drugs, devices, and technologies. They will provide updates about their business, pipelines, and future plans. Further information and registration information can be found here.